(19)
(11) EP 3 891 151 A1

(12)

(43) Date of publication:
13.10.2021 Bulletin 2021/41

(21) Application number: 19829406.8

(22) Date of filing: 05.12.2019
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
A61P 29/00(2006.01)
A61K 31/4985(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4985; C07D 487/04; A61P 29/00
(86) International application number:
PCT/EP2019/083830
(87) International publication number:
WO 2020/115212 (11.06.2020 Gazette 2020/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 05.12.2018 EP 18210338
07.03.2019 EP 19161401

(71) Applicant: LEK Pharmaceuticals d.d.
1526 Ljubljana (SI)

(72) Inventor:
  • LENGAUER, Hannes
    6250 Kundl (AT)

(74) Representative: Prüfer & Partner mbB Patentanwälte · Rechtsanwälte 
Sohnckestraße 12
81479 München
81479 München (DE)

   


(54) CRYSTALLINE PHOSPHATE SALT OF SELECTIVE JAK1 INHIBITOR UPADACITINIB